QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Circulating tumor DNA to predict response and resistance by anti-PD-1 therapy in Chinese relapsed/refractory classic Hodgkin lymphoma. 会议论文 Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019 作者:  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua;  Qian, Wenbin 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/31 Sintilimab for relapsed/refractory classical Hodgkin's lymphoma: Extended follow-up on the multicenter, single-arm phase II ORIENT-1 study. 会议论文 Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019 作者:  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua;  Qian, Wenbin 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/31 Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS) 会议论文 BLOOD, 2016-12-02 作者:  Hu, Shaoxuan;  Song, Yuqin;  Li, Yufu;  Sun, Xiuhua;  Su, Liping 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma 会议论文 作者:  Sun, Zimin;  Feng, Jifeng;  Wu, Jianqiu;  Song, Yongping;  Su, Liping 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05